Covid-19 roundup: Merck's pill sees heavy use; Moderna faces off against Pfizer in vaccine race for youngest kids
Merck’s new Covid-19 pill molnupiravir barely cleared an FDA advisory committee vote (13-10) on the way to its EUA.
And although the FDA and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
